Correlation Between Viridian Therapeutics and Gossamer Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Gossamer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Gossamer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Gossamer Bio, you can compare the effects of market volatilities on Viridian Therapeutics and Gossamer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Gossamer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Gossamer Bio.

Diversification Opportunities for Viridian Therapeutics and Gossamer Bio

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Viridian and Gossamer is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Gossamer Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gossamer Bio and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Gossamer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gossamer Bio has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Gossamer Bio go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Gossamer Bio

Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.08 times more return on investment than Gossamer Bio. However, Viridian Therapeutics is 1.08 times more volatile than Gossamer Bio. It trades about 0.09 of its potential returns per unit of risk. Gossamer Bio is currently generating about 0.04 per unit of risk. If you would invest  1,447  in Viridian Therapeutics on November 2, 2024 and sell it today you would earn a total of  561.00  from holding Viridian Therapeutics or generate 38.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Gossamer Bio

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Gossamer Bio 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Gossamer Bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Gossamer Bio unveiled solid returns over the last few months and may actually be approaching a breakup point.

Viridian Therapeutics and Gossamer Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Gossamer Bio

The main advantage of trading using opposite Viridian Therapeutics and Gossamer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Gossamer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will offset losses from the drop in Gossamer Bio's long position.
The idea behind Viridian Therapeutics and Gossamer Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon